Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS Health Stock Surges as Q1 Results Handily Top Estimates
09:36am, Thursday, 01'st May 2025
CVS Health (CVS) shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results handily topped estimates.
CVS Health (CVS) Q1 Earnings and Revenues Beat Estimates
08:40am, Thursday, 01'st May 2025
CVS Health (CVS) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.31 per share a year ago.
CVS Health's stock surges toward a one-year high after an earnings triple play
06:41am, Thursday, 01'st May 2025
Shares of CVS Health Corp. CVS jumped 6.6% toward a one-year high in premarket trading Thursday, after the healthcare-services company and drugstore chain scored a triple-play with its earnings report
CVS Health raises annual profit forecast as turnaround gathers steam
06:35am, Thursday, 01'st May 2025
CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, signalling an early recovery after a series of troubles hit the healthcare conglomerate
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
06:31am, Thursday, 01'st May 2025
CVS Health said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Under a new partnership between Caremark
CVS tops estimates, hikes guidance as insurance business shows some improvement
06:31am, Thursday, 01'st May 2025
CVS Health reported first-quarter revenue and profit that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period. The company now expec
CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
06:30am, Thursday, 01'st May 2025
First Quarter Financial Highlights Total revenues increased to $94.6 billion, up 7.0% compared to prior year GAAP diluted EPS of $1.41 and Adjusted EPS of $2.25 Generated cash flow from operations of
CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business
06:30am, Thursday, 01'st May 2025
The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.
CVS Health Reports Earnings Thursday. The Stock Is Hot.
04:30pm, Wednesday, 30'th Apr 2025
The stock has gained nearly 50% so far this year.
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
10:35am, Wednesday, 30'th Apr 2025
The first-quarter 2025 earnings season is underway, with a number of top MedTech companies already releasing their numbers. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Gear Up for CVS Health (CVS) Q1 Earnings: Wall Street Estimates for Key Metrics
10:22am, Monday, 28'th Apr 2025
Evaluate the expected performance of CVS Health (CVS) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
11:07am, Thursday, 24'th Apr 2025
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
10:05am, Thursday, 24'th Apr 2025
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CVS Health (CVS) Ascends But Remains Behind Market: Some Facts to Note
06:50pm, Tuesday, 22'nd Apr 2025
In the most recent trading session, CVS Health (CVS) closed at $65.45, indicating a +0.43% shift from the previous trading day.
CVS Soars 53% in Q1: Time to Buy the Stock Ahead of Earnings Release?
04:00pm, Tuesday, 22'nd Apr 2025
Caremark, CVS Health's PBM business, is expected to have continued to play a vital role in offsetting the rising cost of branded drugs during the first quarter.
